Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C
Background: There are many laboratory indices to assess liver fibrosis. Aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) index have been used as well-known serum markers of liver fibrosis. With the increasing use of non-invasive fibrosis assessment, it is important to...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-08-01
|
Series: | Journal of Microbiology, Immunology and Infection |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1684118219301380 |
id |
doaj-164bf3ea78724cae995fd752df44fc2d |
---|---|
record_format |
Article |
spelling |
doaj-164bf3ea78724cae995fd752df44fc2d2020-11-25T03:20:40ZengElsevierJournal of Microbiology, Immunology and Infection1684-11822020-08-01534542549Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis CChun-Han Cheng0Chia-Ying Chu1Huan-Lin Chen2I-Tsung Lin3Chia-Hsien Wu4Yuan-Kai Lee5Ping-Jen Hu6Ming-Jong Bair7Division of Gastroenterology, Department of Internal Medicine, Taitung Mackay Memorial Hospital, Taiwan; Mackay Medical College, New Taipei, TaiwanDepartment of Pathology, Taitung Mackay Memorial Hospital, TaiwanDivision of Gastroenterology, Department of Internal Medicine, Taitung Mackay Memorial Hospital, Taiwan; Mackay Medical College, New Taipei, TaiwanDivision of Gastroenterology, Department of Internal Medicine, Taitung Mackay Memorial Hospital, Taiwan; Mackay Medical College, New Taipei, TaiwanDivision of Gastroenterology, Department of Internal Medicine, Taitung Mackay Memorial Hospital, Taiwan; Mackay Medical College, New Taipei, TaiwanDivision of Gastroenterology, Department of Internal Medicine, Taitung Mackay Memorial Hospital, Taiwan; Mackay Medical College, New Taipei, TaiwanDivision of Gastroenterology, Department of Internal Medicine, Taitung Mackay Memorial Hospital, Taiwan; Mackay Medical College, New Taipei, TaiwanDivision of Gastroenterology, Department of Internal Medicine, Taitung Mackay Memorial Hospital, Taiwan; Mackay Medical College, New Taipei, Taiwan; Corresponding author. Division of Gastroenterology, Department of Internal Medicine, Taitung Mackay Memorial Hospital, Number 1, Lane 303, Changsha Street, Taitung, Taiwan. Fax: +886 89 310150.Background: There are many laboratory indices to assess liver fibrosis. Aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) index have been used as well-known serum markers of liver fibrosis. With the increasing use of non-invasive fibrosis assessment, it is important to recognize the limitations of these tests. The factors influencing the diagnostic accuracy to evaluate liver fibrosis are not well-established. This study aimed to perform a subgroup analysis of the predictive ability of laboratory indices. Methods: Overall, 113 patients with chronic hepatitis C infection who underwent liver biopsy were retrospectively examined. The histological assessment of liver fibrosis was performed using the METAVIR scoring system, and the values of several laboratory tests were also evaluated on the same day. We categorized our study population by treatment status, body mass index (BMI), and age. Results: The two laboratory indices APRI and FIB-4 index could predict advanced (F3-4) liver fibrosis and cirrhosis (F4), with the area under the receiver operating characteristic curve (AUROC) > 0.8 and accuracy >70%. The AUROCs and accuracies were higher among patients with sustained virological response (SVR) than among those without SVR. A higher predictive ability was also observed among patients with BMI <25 kg/m2. Age did not appear to affect liver fibrosis predictability. Conclusions: The laboratory indices APRI and FIB-4 index exhibit good diagnostic performance for determining advanced fibrosis and cirrhosis among patients with hepatitis C infection. The diagnostic accuracy appears better among patients with SVR and those with BMI <25 kg/m2.http://www.sciencedirect.com/science/article/pii/S1684118219301380BiopsyFibrosisHepatitis CHistology |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chun-Han Cheng Chia-Ying Chu Huan-Lin Chen I-Tsung Lin Chia-Hsien Wu Yuan-Kai Lee Ping-Jen Hu Ming-Jong Bair |
spellingShingle |
Chun-Han Cheng Chia-Ying Chu Huan-Lin Chen I-Tsung Lin Chia-Hsien Wu Yuan-Kai Lee Ping-Jen Hu Ming-Jong Bair Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C Journal of Microbiology, Immunology and Infection Biopsy Fibrosis Hepatitis C Histology |
author_facet |
Chun-Han Cheng Chia-Ying Chu Huan-Lin Chen I-Tsung Lin Chia-Hsien Wu Yuan-Kai Lee Ping-Jen Hu Ming-Jong Bair |
author_sort |
Chun-Han Cheng |
title |
Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C |
title_short |
Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C |
title_full |
Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C |
title_fullStr |
Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C |
title_full_unstemmed |
Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C |
title_sort |
subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (apri) and fibrosis-4 (fib-4) for assessing hepatic fibrosis among patients with chronic hepatitis c |
publisher |
Elsevier |
series |
Journal of Microbiology, Immunology and Infection |
issn |
1684-1182 |
publishDate |
2020-08-01 |
description |
Background: There are many laboratory indices to assess liver fibrosis. Aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) index have been used as well-known serum markers of liver fibrosis. With the increasing use of non-invasive fibrosis assessment, it is important to recognize the limitations of these tests. The factors influencing the diagnostic accuracy to evaluate liver fibrosis are not well-established. This study aimed to perform a subgroup analysis of the predictive ability of laboratory indices. Methods: Overall, 113 patients with chronic hepatitis C infection who underwent liver biopsy were retrospectively examined. The histological assessment of liver fibrosis was performed using the METAVIR scoring system, and the values of several laboratory tests were also evaluated on the same day. We categorized our study population by treatment status, body mass index (BMI), and age. Results: The two laboratory indices APRI and FIB-4 index could predict advanced (F3-4) liver fibrosis and cirrhosis (F4), with the area under the receiver operating characteristic curve (AUROC) > 0.8 and accuracy >70%. The AUROCs and accuracies were higher among patients with sustained virological response (SVR) than among those without SVR. A higher predictive ability was also observed among patients with BMI <25 kg/m2. Age did not appear to affect liver fibrosis predictability. Conclusions: The laboratory indices APRI and FIB-4 index exhibit good diagnostic performance for determining advanced fibrosis and cirrhosis among patients with hepatitis C infection. The diagnostic accuracy appears better among patients with SVR and those with BMI <25 kg/m2. |
topic |
Biopsy Fibrosis Hepatitis C Histology |
url |
http://www.sciencedirect.com/science/article/pii/S1684118219301380 |
work_keys_str_mv |
AT chunhancheng subgroupanalysisofthepredictiveabilityofaspartateaminotransferasetoplateletratioindexapriandfibrosis4fib4forassessinghepaticfibrosisamongpatientswithchronichepatitisc AT chiayingchu subgroupanalysisofthepredictiveabilityofaspartateaminotransferasetoplateletratioindexapriandfibrosis4fib4forassessinghepaticfibrosisamongpatientswithchronichepatitisc AT huanlinchen subgroupanalysisofthepredictiveabilityofaspartateaminotransferasetoplateletratioindexapriandfibrosis4fib4forassessinghepaticfibrosisamongpatientswithchronichepatitisc AT itsunglin subgroupanalysisofthepredictiveabilityofaspartateaminotransferasetoplateletratioindexapriandfibrosis4fib4forassessinghepaticfibrosisamongpatientswithchronichepatitisc AT chiahsienwu subgroupanalysisofthepredictiveabilityofaspartateaminotransferasetoplateletratioindexapriandfibrosis4fib4forassessinghepaticfibrosisamongpatientswithchronichepatitisc AT yuankailee subgroupanalysisofthepredictiveabilityofaspartateaminotransferasetoplateletratioindexapriandfibrosis4fib4forassessinghepaticfibrosisamongpatientswithchronichepatitisc AT pingjenhu subgroupanalysisofthepredictiveabilityofaspartateaminotransferasetoplateletratioindexapriandfibrosis4fib4forassessinghepaticfibrosisamongpatientswithchronichepatitisc AT mingjongbair subgroupanalysisofthepredictiveabilityofaspartateaminotransferasetoplateletratioindexapriandfibrosis4fib4forassessinghepaticfibrosisamongpatientswithchronichepatitisc |
_version_ |
1724617319512014848 |